ANI Pharmaceuticals, Inc. (ANIP) Earnings History
Profitable28 years of earnings data (1998–2025) · Positive TTM net income
Loading earnings history...
ANI Pharmaceuticals, Inc. (ANIP) Earnings Overview
As of June 23, 2026, ANI Pharmaceuticals, Inc. (ANIP) reported trailing twelve-month net income of $90M, reflecting +419.2% year-over-year growth. The company earned $4.16 per diluted share over the past four quarters, with a net profit margin of 8.9%.
Looking at the long-term picture, ANIP's historical earnings data spans multiple years. The company achieved its highest annual net income of $78M in fiscal 2025, representing a new all-time high.
ANI Pharmaceuticals, Inc. maintains positive profitability with a gross margin of 51.0%, operating margin of 9.2%, and net margin of 8.9%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AMRX ($72M net income, 2.4% margin), LNTH ($279M net income, 15.2% margin), PRGO (-$1.82B net income, -33.5% margin), ANIP has outperformed on profitability metrics. Compare ANIP vs AMRX →
ANIP Earnings vs Peers
Earnings metrics vs comparable public companies
ANIP Historical Earnings Data (1998–2025)
28 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $78M | +522.9% | $81M | $3.32 | 8.9% | 9.2% |
| 2024 | -$19M | -198.6% | $584,000 | $-1.04 | -3.0% | 0.1% |
| 2023 | $19M | +139.2% | $47M | $0.94 | 3.9% | 9.6% |
| 2022 | -$48M | -12.4% | -$35M | $-3.05 | -15.1% | -11.2% |
| 2021 | -$43M | -88.9% | -$40M | $-3.40 | -19.7% | -18.4% |
| 2020 | -$23M | -470.0% | -$16M | $-1.88 | -10.8% | -7.7% |
| 2019 | $6M | -60.7% | $16M | $0.50 | 3.0% | 7.9% |
| 2018 | $15M | +1540.0% | $35M | $1.32 | 7.7% | 17.5% |
| 2017 | -$1M | -127.4% | $28M | $-0.09 | -0.6% | 16.0% |
| 2016 | $4M | -74.4% | $20M | $0.34 | 3.1% | 15.6% |
| 2015 | $15M | -46.5% | $33M | $1.32 | 20.1% | 42.8% |
| 2014 | $29M | +9450.5% | $20M | $2.59 | 51.4% | 35.7% |
| 2013 | $301,000 | +101.1% | $898,000 | $-0.92 | 1.0% | 3.0% |
| 2012 | -$28M | +46.3% | -$23M | $-7.64 | -1204.7% | -1007.1% |
| 2011 | -$52M | -11.7% | -$51M | $-18.88 | -11859.7% | -11703.0% |
| 2010 | -$46M | +2.8% | -$44M | $-25.23 | -1867.1% | -1762.5% |
| 2009 | -$48M | -172.8% | -$38M | $-50.39 | -3777.9% | -3054.4% |
| 2008 | -$17M | -129.7% | -$18M | $-22.97 | -460.9% | -476.4% |
| 2007 | -$8M | -371.7% | -$9M | $-10.71 | -1538.3% | -1760.3% |
| 2006 | $3M | +128.9% | $3M | $4.68 | 19.3% | 23.8% |
| 2005 | -$10M | +19.7% | -$9M | $-17.92 | -3735.6% | -3600.6% |
| 2004 | -$12M | -101.6% | -$12M | $-25.23 | -15427.9% | -15749.5% |
| 2003 | -$6M | -56.4% | -$6M | $-19.44 | -9099.1% | -9231.3% |
| 2002 | -$4M | -45.9% | -$4M | $-18.28 | -134.5% | -134.5% |
| 2001 | -$3M | +24.0% | -$3M | $-14.50 | -149.4% | -159.4% |
| 2000 | -$3M | -144.4% | -$4M | $-21.51 | - | - |
| 1999 | -$1M | +47.1% | -$2M | $-10.24 | - | - |
| 1998 | -$3M | - | -$3M | $-0.27 | -2161.1% | -2161.1% |
Download Data
Export ANIP earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
28+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ANIP — Frequently Asked Questions
Quick answers to the most common questions about buying ANIP stock.
What is ANIP earnings per share (EPS)?
ANIP trailing twelve-month (TTM) diluted EPS is $4.16, reflecting +419.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1998 to 2025 is available in the table on this page.
What is ANI Pharmaceuticals, Inc.'s net income?
ANI Pharmaceuticals, Inc. (ANIP) trailing twelve-month net income is $90M as of 2025. Earnings grew +419.2% year-over-year.
Is ANIP profitable?
Yes, ANIP is profitable with a TTM net income of $90M and a net profit margin of +8.9%.
What is ANIP's earnings growth rate?
ANIP compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: +9.7%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1998 to 2025.
What are ANIP's profit margins?
ANI Pharmaceuticals, Inc. net profit margin is +8.9%, operating margin is +9.2%, and gross margin is +51.0%. Margins are within a typical range for the sector. Return on Equity is +16.2%.
Is ANIP growing earnings?
Yes, ANIP earnings are accelerating — EPS growth of +419.2% exceeds the 5-year CAGR of N/A. TTM net income reached $90M. Earnings momentum is strengthening.
What was ANIP's best earnings year?
ANI Pharmaceuticals, Inc.'s highest annual net income on record is $78M, achieved in fiscal year 2025. Earnings history on this page spans 1998 to 2025 and includes all annual and quarterly figures.
What were ANIP's earnings last quarter?
ANIP's most recent reported quarter was Q1 2026. Net income was $29M with diluted EPS of $1.28. For a full breakdown of all quarters, see the quarterly earnings table on this page.